Cargando…
Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment
Melanoma, a highly aggressive skin tumor, exhibits notable features including heterogeneity, a high mutational load, and innate immune escape. Despite advancements in melanoma treatment, current immunotherapies fail to fully exploit the immune system’s maximum potential. Activating immunogenic cell...
Autores principales: | Wang, Jiandong, Ma, Jinyuan, Tai, Zongguang, Li, Lisha, Zhang, Tingrui, Cheng, Tingting, Yu, Junxia, Zhu, Quangang, Bao, Leilei, Chen, Zhongjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697015/ http://dx.doi.org/10.2147/IJN.S434582 |
Ejemplares similares
-
Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: Predict before protect
por: Zhang, Xinyue, et al.
Publicado: (2022) -
Advance and Challenges in the Treatment of Skin Diseases with the Transdermal Drug Delivery System
por: Cheng, Tingting, et al.
Publicado: (2023) -
Physical therapy in diabetic foot ulcer: Research progress and clinical application
por: Huang, Hao, et al.
Publicado: (2023) -
Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer
por: Tai, Zongguang, et al.
Publicado: (2020) -
Lycorine transfersomes modified with cell-penetrating peptides for topical treatment of cutaneous squamous cell carcinoma
por: Li, Ying, et al.
Publicado: (2023)